Opinions
Jaime Carrasco
Medipharm Labs Corp
LABS-T
RISKY
Mar 27, 2020
He has as $6.75 as a speculative buy. He thinks sales continue to track along and thinks this down turn may be the best thing for them. When it comes to CBD oil production everything is being produced in North America. The industry as a whole has been consolidating, but he is still going to wait before buying in as whole.
N/A
Stock price when the opinion was issued
agriculture
It's the ideal tool to help you make quicker, more informed decisions for
managing and tracking your investments.
You might be interested:
HOLD
An extractor of oils from cannabis. They have the ability to move beyond CBD and THC extraction, into more of a pharmaceutical oil. They have long term contracts. There is some concern they are charging high premiums for extraction, so their margins may shrink in the future. This is not likely to harm them for the next five year, he thinks. A good cash flow producing stock in this space.
agriculture
COMMENT
It is pure extraction. There are probably 3 or 4 of them. They are a leader. There are not too many companies here that are profitable and these guys are one of them. They do toll extracting for clients as well as getting their own Cannabis and extracting from them. They make a great margin.
agriculture